These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8989184)

  • 1. A comparison of bactericidal/permeability-increasing protein variant versus recombinant endotoxin-neutralizing protein for the treatment of Escherichia coli sepsis in rats .
    Stack AM; Saladino RA; Siber GR; Thompson C; Marra MN; Novitsky TJ; Fleisher GR
    Crit Care Med; 1997 Jan; 25(1):101-5. PubMed ID: 8989184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of early and late treatment with a recombinant endotoxin neutralizing protein in a rat model of Escherichia coli sepsis.
    Weiner DL; Kuppermann N; Saladino RA; Thompson CM; Novitsky TJ; Siber GR; Fleisher GR
    Crit Care Med; 1996 Sep; 24(9):1514-7. PubMed ID: 8797624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant endotoxin neutralizing protein improves survival from Escherichia coli sepsis in rats.
    Nelson D; Kuppermann N; Fleisher GR; Hammer BK; Thompson CM; Garcia CT; Novitsky TJ; Parsonnet J; Onderdonk A; Siber GR
    Crit Care Med; 1995 Jan; 23(1):92-8. PubMed ID: 8001394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose recombinant endotoxin neutralizing protein improves survival in rabbits, with Escherichia coli sepsis.
    Saladino RA; Stack AM; Thompson C; Sattler F; Novitsky TJ; Siber GR; Fleisher GR
    Crit Care Med; 1996 Jul; 24(7):1203-7. PubMed ID: 8674336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a recombinant endotoxin-neutralizing protein with a human monoclonal antibody to endotoxin for the treatment of Escherichia coli sepsis in rats.
    Kuppermann N; Nelson DS; Saladino RA; Thompson CM; Sattler F; Novitsky TJ; Fleisher GR; Siber GR
    J Infect Dis; 1994 Sep; 170(3):630-5. PubMed ID: 8077721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a recombinant endotoxin neutralizing protein in rabbits with Escherichia coli sepsis.
    Saladino R; Garcia C; Thompson C; Hammer B; Parsonnet J; Novitsky T; Siber G; Fleisher G
    Circ Shock; 1994 Feb; 42(2):104-10. PubMed ID: 8013061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of a recombinant N-terminal fragment of bactericidal/permeability-increasing protein and cefamandole in treatment of rabbit gram-negative sepsis.
    Lin Y; Leach WJ; Ammons WS
    Antimicrob Agents Chemother; 1996 Jan; 40(1):65-9. PubMed ID: 8787881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of hemorrhage-induced bacteria/endotoxin translocation in rats. Effects of recombinant bactericidal/permeability-increasing protein.
    Yao YM; Bahrami S; Leichtfried G; Redl H; Schlag G
    Ann Surg; 1995 Apr; 221(4):398-405. PubMed ID: 7726676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endotoxin-binding and -neutralizing properties of recombinant bactericidal/permeability-increasing protein and monoclonal antibodies HA-1A and E5.
    Marra MN; Thornton MB; Snable JL; Wilde CG; Scott RW
    Crit Care Med; 1994 Apr; 22(4):559-65. PubMed ID: 8143464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of bactericidal permeability-increasing protein in the treatment of gram-negative pneumonia.
    Kelly CJ; Cech AC; Argenteanu M; Gallagher H; Shou J; Minnard E; Daly JM
    Surgery; 1993 Aug; 114(2):140-6. PubMed ID: 8342120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human neutrophil bactericidal/permeability-increasing protein reduces mortality rate from endotoxin challenge: a placebo-controlled study.
    Fisher CJ; Marra MN; Palardy JE; Marchbanks CR; Scott RW; Opal SM
    Crit Care Med; 1994 Apr; 22(4):553-8. PubMed ID: 8143463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-endotoxin therapy in primate bacteremia with HA-1A and BPI.
    Rogy MA; Moldawer LL; Oldenburg HS; Thompson WA; Montegut WJ; Stackpole SA; Kumar A; Palladino MA; Marra MN; Lowry SF
    Ann Surg; 1994 Jul; 220(1):77-85. PubMed ID: 8024362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of bactericidal/permeability-increasing protein in the treatment of primate bacteremia and septic shock.
    Rogy MA; Oldenburg HS; Calvano SE; Montegut WJ; Stackpole SA; Van Zee KJ; Marra MN; Scott RW; Seilhammer JJ; Moldawer LL
    J Clin Immunol; 1994 Mar; 14(2):120-33. PubMed ID: 8195314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of different classes antimicrobial agents on plasma endotoxin activity.
    Nitsche D; Schulze C; Oesser S; Dalhoff A; Sack M
    Arch Surg; 1996 Feb; 131(2):192-9. PubMed ID: 8611078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a recombinant endotoxin-neutralizing protein on endotoxin shock in rabbits.
    Garcia C; Saladino R; Thompson C; Hammer B; Parsonnet J; Wainwright N; Novitsky T; Fleisher GR; Siber G
    Crit Care Med; 1994 Aug; 22(8):1211-8. PubMed ID: 8045139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety evaluation for a cell-based immune support system in an ex vivo rat model of gram-negative sepsis.
    Sauer M; Altrichter J; Kreutzer HJ; Schmidt H; Nöldge-Schomburg G; Schmidt R; Mitzner SR
    Ther Apher Dial; 2009 Oct; 13(5):444-50. PubMed ID: 19788463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of an N-terminal fragment of bactericidal/permeability-increasing protein in rodent models of gram-negative sepsis: role of bactericidal properties.
    Ammons WS; Kohn FR; Kung AH
    J Infect Dis; 1994 Dec; 170(6):1473-82. PubMed ID: 7995987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of a recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in an animal model of gram-negative sepsis.
    Evans TJ; Carpenter A; Moyes D; Martin R; Cohen J
    J Infect Dis; 1995 Jan; 171(1):153-60. PubMed ID: 7798655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant N-terminal fragment of bactericidal/permeability increasing protein (rBPI21) prevents shock-induced microcirculatory alterations in the liver.
    Bauer C; Riemer-Paxian I; Larsen R; Marzi I
    Crit Care Med; 1997 Aug; 25(8):1283-8. PubMed ID: 9267939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The recombinant 23-kDa N-terminal fragment of bactericidal/permeability-increasing protein (rBPI23) decreases Escherichia coli-induced mortality and organ injury during immunosuppression-related neutropenia.
    Lechner AJ; Lamprech KE; Johanns CA; Matuschak GM
    Shock; 1995 Oct; 4(4):298-306. PubMed ID: 8564560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.